ADIPOQ and gestational diabetes: Research supports the circulating biomarkers of the first trimester, such as blood sugar, fasting insulin, adiponectin, HDL-c, triglycerides, and C-reactive protein (39), which may predict an enhanced possibility of GDM risk.